All patients (N = 117) | Training cohort (N = 64) | Validation cohort (N = 53) | P value | |
Age (year) (Median, QR) | 60.0[55.0; 64.0] | 61.0 [55.0; 65.0] | 60.0[56.0; 63.0] | 0.331 |
Gender | 0.138 | |||
Female | 8 (6.84%) | 2 (3.12%) | 6 (11.3%) | |
Male | 109 (93.2%) | 62 (96.9%) | 47 (88.7%) | |
Tumor cell differentiation | 0.013 | |||
Well differentiation | 66 (56.4%) | 29 (45.3%) | 37 (69.8%) | |
Poor differentiation | 51 (43.6%) | 35 (54.7%) | 16 (30.2%) | |
Maximum tumor diameter in CT | 0.498 | |||
<3.6 cm | 70 (59.8%) | 36 (56.2%) | 36 (56.2%) | |
≥3.6 cm | 47 (40.2%) | 28 (43.8%) | 28 (43.8%) | |
LNM status in CT | 0.254 | |||
No | 41 (35.0%) | 19 (29.7%) | 22 (41.5%) | |
Yes | 76 (65.0%) | 45 (70.3%) | 31 (58.5%) | |
Ki67 expression level | 0.436 | |||
Low | 43 (36.8%) | 21 (32.8%) | 21 (32.8%) | |
High | 74 (63.2%) | 43 (67.2%) | 31 (58.5%) | |
STMN1 expression level | 0.135 | |||
Low | 37 (31.6%) | 16 (25.0%) | 21 (39.6%) | |
High | 80 (68.4%) | 48 (75.0%) | 32 (60.4%) | |
Vascular invasion status | 1.000 | |||
No | 69 (59.0%) | 38 (59.4%) | 31 (58.5%) |
|
Yes | 48 (41.0%) | 26 (40.6%) | 22 (41.5%) | |
Lymph vessels invasion status | 1.000 | |||
No | 51 (43.6%) | 28 (43.8%) | 23 (43.4%) | |
Yes | 66 (56.4%) | 36 (56.2%) | 30 (56.6%) | |
LNM in pathology | 0.576 | |||
No | 27 (23.1%) | 13 (20.3%) | 14 (26.4%) | |
Yes | 90 (76.9%) | 51 (79.7%) | 39 (73.6%) |